Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Abdul Samad Hashimi

Thoracic Surgery (Cardiothoracic Vascular Surgery) Phoenix, AZ Medical Doctor

NPI 1588873715 CMS profile 1035146

500 W Thomas Rd Ste 500, Phoenix, AZ 85013

Open in the dashboard

General payments

$175,034

206 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Abdul Samad Hashimi of Phoenix, AZ is reported in the CMS Open Payments database as having received $175,034 across 206 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,587 23
2024 General $39,790 44
2023 General $24,660 44
2022 General $31,473 36
2021 General $12,586 9
2020 General $12,881 16
2019 General $33,057 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Abdul Samad Hashimi
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Abdul Samad Hashimi were reported at $20,587. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Abdul Samad Hashimi Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $33,057 $886 $178–$3,167 $163
2020 $12,881 $341 $108–$1,605 $114
2021 $12,586 $453 $125–$1,886 $132
2022 $31,473 $695 $180–$2,566 $149
2023 $24,660 $745 $205–$2,662 $160
2024 $39,790 $799 $214–$2,967 $164
2025 $20,587 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $172,564 189 payments
  2. XVIVO Perfusion Inc. $934 2 payments
  3. Paragonix Technologies, Inc. $439 2 payments
  4. Abbott Laboratories $324 2 payments
  5. AstraZeneca Pharmaceuticals LP $307 3 payments
  6. Davol Inc. $257 3 payments
  7. United Therapeutics Corporation $79 1 payment
  8. Medtronic, Inc. $62 1 payment
  9. Atricure, Inc. $43 2 payments
  10. Stryker Corporation $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $142,131 38 payments
  2. Travel and Lodging $16,479 73 payments
  3. Food and Beverage $12,425 94 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $172,564 189 payments
  2. XVIVO Perfusion System (XPS) $934 2 payments
  3. LungGuard $439 2 payments
  4. LiverGuard $439 2 payments
  5. PancreasPak $439 2 payments
  6. BaroGuard $439 2 payments
  7. SherpaPak $439 2 payments
  8. TAGRISSO $217 2 payments
  9. Progel Applicator Spray Tips $200 2 payments
  10. MITRACLIP $179 1 payment
  11. Other $410 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$69,818

Medicare's payments for the services billed

Medicare patients

68

Average age 71

Services billed

145

30 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 68%
COPD 66%
Arthritis 59%
Atrial fibrillation 51%
Depression 40%
Diabetes 35%
Chronic kidney disease 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

206 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record